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Acute mitral regurgitation (MR) is a frequent complication of acute myocardial infarction,
with a variable presentation depending on the severity of MR and the integrity of the
subvalvular apparatus. While most cases are asymptomatic or have mild dyspnea, rupture
of chordae tendinea or papillary muscles are catastrophic complications that may rapidly
lead to cardiogenic shock and death. Despite the presence of pulmonary edema and/or
cardiogrenic shock, the murmur of acute MR is usually subtle due to rapid equalization of
left atrial and left ventricular pressure gradient, and therefore misleading. Echocardiog-
raphy is the deﬁnite diagnostic modality, allowing quantiﬁcation of the severity of MR
and the structural abnormalities within the subvalvular apparatus. Severe MR accompa-
nied by rupture of chordae or papillary muscles should be managed with temporary
stabilization with medical treatment or with mechanical circulatory support, with sub-
sequent surgical intervention to repair or replace the valve.1. Introduction
Several pathogenic mechanisms and dynamics may lead to
ischemic mitral regurgitation (MR) after an acute myocardial
infarction (MI). These mechanisms include papillary muscle
ischemia and changes in left ventricular (LV) geometry[1–4].
Papillary muscle dysfunction, as well as partial/complete
rupture of a papillary muscle or mitral chordae may cause
hemodynamic instability due to acute mitral regurgitation, with
subsequent pulmonary edema or cardiogenic shock, eventually
resulting with poor short-term outcomes. All mechanical com-
plications of an acute MI are life-threatening (rupture of ven-
tricular free wall, papillary muscle or ventricular septum) and
require early recognition and prompt initiation of aggressive
treatment[5].
2. Epidemiology
The advent of primary percutaneous coronary intervention,
which is one of the most important therapeutic interventions foracute ST elevation MI in the present era, reduced the general
incidence of mechanical complications (< 1%)[2,5–8]. The
incidence for papillary muscle rupture has been reported
between 0.25% or 0.26% in contemporary registries. These
ﬁgures were much higher in older studies, with a reported
incidence between 1% and 5%, and in average 2.3% of
patients with an acute myocardial infarction experienced a
mechanical complication[2,6,9–11]. Nevertheless, mortality due to
mechanical complications following an acute MI remains
unacceptably high (around above 50%)[5], and cardiogenic
shock is still as an important cause for early mortality despite
improvements in therapeutic strategies, complicating 3%–7%
of cases with acute MI[12–16]. In several trials, it has been
observed that a higher proportion of cardiogenic shocks were
caused by acute MR in women. This was attributed to several
factors related to gender-speciﬁc predisposition, such as differ-
ences in patterns of mitral/papillary vascular supply, collateral-
ization and structural differences within the connective tissue,
but the exact cause remains unknown[9,17,18].
3. Pathophysiology
Mitral valve is composed of mitral leaﬂets and the sub-
valvular apparatus (chordae tendineae and papillary muscles),
which are parts of the LV and are altered by functional and
structural changes in LV. The relationship is bidirectional, as the
alterations within the subvalvular apparatus itself could induces article under the CC BY-NC-ND license
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papillary muscles (anterolateral and posteromedial) arising
from the left ventricle originate from embriologic trabeculae
carneae, and in order to ensure valvular competence during the
ventricular systole, they are attached beneath the ipsilateral
commissures of the mitral valve[6,20]. Each papillary muscle is
connected to both leaﬂets via chordae tendinea[6,11,20]. Ischemic
MR due to papillary dysfunction/rupture is associated with
two mechanisms, namely, interruption of the coronary blood
supply and alterations within the LV geometry.
Subendocardial branches of coronary arteries supplying
papillary muscles cross through the full thickness of
myocardium. These arteries have a very long intramyocardial
course, making them vulnerable to ischemia[6]. Anterolateral
papillary muscle (ALPM) receives blood supply from two
major coronary branches, left anterior descending and left
circumﬂex artery (LCx). However, blood supply to the
posteromedial papillary muscle (PMPM) is limited to a single
coronary artery, the posterior descending artery originating
either from right coronary artery in right dominant systems or
from the LCx in left dominant systems. Rupture or infarction
of the posteromedial muscle occur more frequently as it
receives blood supply from a single source[2,6,11]. According to
various registries, the rupture of PMPM is six to twelve times
more frequent than the rupture ALPM[6,20–22]. In most instances,
the rupture of PMPM is partial and does not involve full
thickness of the muscle. In contrast, complete rupture ofTable 1
Summary for the clinical presentation and ﬁndings in patients with acute mi
Clinical presentation Characteristics
Symptoms - Exertional dyspnea
- Orthopnea
- Palpitations
- Fatigue
- Cough
- Chest discomfort or angina
- Syncope
- Symptoms of inadequate organ perfusion
(cold clammy extremities, sweating, alterati
consciousness).
- Cardiac arrest
Physical examination - New pansystolic murmur best auscultated fr
and radiates to left parasternal bordar or ax
- Jugular venous distension.
- Elevated respiratory rate, inspiratory ﬁne
contraction of accessory respiratory muscles
Electrocardiography - Tachycardia with or without sinus rhythm.
- ST segment elevation in inferior (usual) or
(rarer) leads.
- Non-speciﬁc ﬁndings in some occasions.
Chest X-ray - Bilateral interstitial or alveolar inﬁltrates.
Echocardiography - Severity and mechanism of MR.
- Left ventricular function.
- Motion of left ventricular segments.
- Differential diagnosis for other possible
complications.
Right heart
catheterization
- Elevated pulmonary arterial pressure and
pulmonary capillary wedge pressure.
- Giant V or CV waves.ALPM occurs more frequently than complete rupture of
PMPM. This apparent contradiction is explained by different
anatomical properties of each papillary muscle, as ALPM
often has single body or head, while the posteromedial
papillary muscle usually includes two bodies or heads[6,19,23]. In
addition, the majority of MR cases caused by rupture or
dysfunction of papillary muscle are due to relatively small
infarctions. Since the jeopardized myocardial mass is rather
small, LV function is usually well-maintained in these patients
(median LV EF is 35%–37% according to various
registries)[6,9,21,24,25].
4. Signs and symptoms
Signs and symptoms are quite variable, ranging from mild
dyspnea to cardiopulmonary arrest (Table 1). Following an acute
MI complicated with acute MR, hemodynamic stability depends
on the integrity of the subvalvular apparatus, presence of
valvular dysfunction and the extent and location of myocardial
damage[1,16]. The time to papillary muscle rupture following an
acute MI was cited as 1–14 days in older studies, with the
days 2–7 constituting the most vulnerable period[2,5,11,26,27]. In
SHOCK registry, however, the average time to papillary
muscle rupture was 13 h[1,9]. A complete rupture generally
results with cardiogenic shock and death, while the partial
rupture of a papillary muscle or associated chordae usually
presents with respiratory distress or pulmonary edema rathertral regurgitation complicating an acute myocardial infarction.
Findings
Symptoms are unreliable for the estimation of the
underlying pathology due to high variability.
Complete or incomplete papillary muscle rupture is
frequently accompanied by cardiogenic shock or
cardiac arrest.
ons in
om apex
illa.
No direct correlation between the severity of murmur
and the severity of MR.
No displacement of cardiac apex.
crackles,
.
Not speciﬁc and reﬂects underlying MI pattern only.
anterior ST segment elevation may be absent despite total
occlusion of left circumﬂex artery.
Cardiomegaly is absent
Transesophageal echocardiography has superior
accuracy and allows better visualization of the valve.
TEE tends to overestimate the severity of MR
preoperatively and underestimate perioperatively.
CV waves could be observed with other
complications, reducing the sensitivity.
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a myriad of symptoms, ranging from cough or vague chest
discomfort to severe shortness of breath or signiﬁcant
angina[11]. Findings from a cardiovascular examination include
tachycardia, along with a new pansystolic murmur loudest at
the cardiac apex and radiating to the axillae, which may also
have a diastolic component. When a PMPM rupture is present,
the murmur may radiate to the left sternal border, which could
be similar to the murmur of ventricular septal rupture (VSR).
There is no direct correlation between the intensity of the
murmur and the severity of MR[1,2,11]. In patients with poor
cardiac output, the murmur may be soft or even absent due to
the reduced pressure gradient between the LV cavity and the
overloaded LA during systole[1]. Jugular venous distention
may be present in some cases. Pulmonary examination may
reveal an elevated respiratory rate, contraction of accessory
respiratory muscles, and bilateral ﬁne crackles at the basal
portion of the lungs or crackles covering both lung ﬁelds[11,28–
30]. Localized pulmonary edema at the right upper lobe may
also be encountered as the regurgitant ﬂow and directed at the
right superior pulmonary vein[1,2].
5. Electrocardiography
ECG usually demonstrates ST segment elevation in the
inferior and posterior leads, while ST elevation in anterior leads
is rarer[11], and only non-speciﬁc ST and T wave alterations are
present in some instances (Table 1). ECG should be routinely
recorded on admission and repeated as needed. This is dictated
by the clinical course, and repeat ECG's should be obtained after
clinical stabilization or further deterioration[2,31]. Whilst ST
elevation of anterior location is the predominant presentation
in patients with LV failure and shock, patients presenting with
pulmonary edema frequently have an ST elevation on
posterior leads[18]. In spite of the fact that more than half of
the MR cohort in SHOCK Trial did not have ST elevation and
new Q waves, in many of these patients it was recognized that
there was complete vessel occlusion and a signiﬁcant
proportion of these had completed occlusion in LCx artery.
This is explained with the scarce use of posterior leads when
the SHOCK Trial Registry was commenced[9]. Alveolar
pulmonary congestion should be conﬁrmed with chest
radiography in patients with acute MI, which shows diffuse
bilateral interstitial or alveolar inﬁltrates without associated
cardiomegaly[11,25,28–30].
6. Echocardiography
Echocardiography should be carried out immediately after
hospital admission in order to conﬁrm the diagnosis of acute MR
when suspected clinically. Beyond conﬁrming the diagnosis,
echocardiography also allows differential diagnosis for other
mechanical complications, such as VSR. Transthoracic echo-
cardiography (TTE) with color ﬂow Doppler is the initial im-
aging modality, having a sensitivity of 65%–85% for the
diagnosis of papillary muscle rupture with concomitant
MR[2,11,32]. Additionally, LV wall motion abnormalities, global
left ventricular function, severity of leaﬂet prolapse, presence
of ﬂail chords or the integrity of papillary muscles could be
assessed with TTE. Transesophageal echocardiography (TEE)
has a superior sensitivity and diagnostic accuracy compared
with TTE since the mitral apparatus is located posteriorly andTEE probe is much closer to the valve, allowing better
visualization (Table 1). This is most pronounced in the pres-
ence of eccentric regurgitant jets coursing towards the posterior
wall of the LA. Therefore, TEE has a diagnostic yield ranging
between 95% and 100%[11,28], for assessing the anatomy of the
mitral valve and identifying the pathophysiology underlying
MR[2,11]. Both TTE and TEE may be used in combination as
different diagnostic modalities if necessary. Akinesia and
hypokinesia involving the inferior and posterior walls in
patients with MR can be detected by both echocardiographic
modalities[25]. TTE generally tends to overestimate the LV
function and underestimate the degree of acute MR, which
could be attributed to hyperdynamic left ventricle in the
presence of an acute MR, poor acoustic windows, resting
tachycardia and rapid equalization of pressure between left
ventricle and left atrium. In contrast, TEE is prone to
overestimate mitral regurgitation in the preoperative period as
the position of the probe is relatively closer to the regurgitant
jet, while it underestimates the degree of MR in perioperative
period due to effects of anesthesia[1,2]. Echocardiography
should be repeated after a new anginal episode, dyspnea or
clinically deterioration in the coronary care unit.
Pulmonary capillary wedge pressure tracings from pulmo-
nary artery may show large V waves in the presence of an acute
MR. However, this ﬁnding is not pathognomonic since it may be
seen in others conditions, such as VSR and massive LV
failure[1,2,33].
7. Management
Treatment of acute MR is varied with respect to underlying
mechanism or type of mitral regurgitation (Table 2). Thus, acute
and chronic ischemic MR require different management strate-
gies as the pathophysiologic mechanisms underlying these
conditions are not same[25]. Mild to moderate chronic MR
following acute MI is seen in 15%–45% of patients[2,34]. These
are usually asymptomatic, well tolerated and addressed with
surgical interventions if needed in the follow up. Acute MR
necessitates emergency treatment if accompanied by
pulmonary edema or cardiogenic shock. In addition,
emergency surgery is indispensable in the presence of an acute
MR resulting from the rupture of a papillary muscle[2,25]. The
patient should be treated immediately with medical therapy to
relieve symptoms and ensure clinical stability in the initial
term. The goal of pharmacological therapy is to obtain a
reduced regurgitant fraction and increased forward stroke
volume via reducing left ventricular ﬁling pressure and
afterload[2,25]. Mechanical support with an intra-aortic balloon
counterpulsation, which decreases afterload and increases aortic
diastolic pressure, can be used to achieve aforementioned ob-
jectives in selected patients. Temporary mechanical cardiac
support with a LV assist device (such as Impella Recover de-
vice) or VA-ECMO can be used to reduce in the cardiac after-
load (for the former) and to improve coronary circulation, end-
organ perfusion and oxygenation in patients with ongoing
cardiogenic shock and severe myocardial ischemia[2,5]. Medical
therapy includes morphine sulfate, nitroglycerin or sodium
nitroprusside (continuous infusion), diuretics and ACE
inhibitors; in addition to standard antiaggregant and
anticoagulant therapies. In patients with hypotension, positive
inotropic agents such as dobutamine and dopamine should be
considered[31].
Table 2
Management strategies in patients with severe acute mitral regurgitation following acute myocardial infarction.
Strategies Treatment
Medications - Vasodilators (nitroglycerine, sodium nitroprusside, morphine sulfate)
- ACE inhibitors
- Diuretics
- Inotropic agents with or without additional vasodilator effects
(dobutamine, dopamine)
Mechanical ventilation - Non-invasive (preferred if the patient is stable)
- Invasive
Intraaortic baloon counterpulsation
Temporary left ventricular assist devices - Impella
- Tandem heart
- Levitronix
- Berlin EXCOR or similar pulsatile pumps
Extracorporeal membrane oxygenation (venoarterial)
Therapeutic hypothermia
Deﬁnite surgical correction
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be used as necessary. While IMV is considered in the setting of
severe pulmonary edema, cardiogenic shock and cardiopulmo-
nary arrest that results with deterioration of consciousness due to
acute and persistent respiratory insufﬁciency (in the arterial
blood gas analysis pO2 < 60 mmHg, pCO2 > 60 mmHg and
respiratory rate > 40 respiration/min), noninvasive mechanic
ventilation is adequate and effective in most episodes of stand-
alone acute pulmonary edema or pulmonary congestion[2,28,31].
IMV is associated with long and short term mortality and is
an independent predictor of mortality[35]. Therapeutic
hypothermia may be applied to patients that do not regain
consciousness following cardiopulmonary resuscitation, with a
target core temperature of 33–34 C achieved by infusing
4 C Ringer solution and surface cooling using an external
cooling system such as the Arctic Sun 2000 gel pads system
(Bard, Covington, Georgia, USA) in the CCU, as suggested
by guidelines[28,36,37].
Emergent cardiac catheterization should be performed to
identify coronary lesions and to bridge to revascularization[2,38,39].
Urgent or emergent surgical intervention, synchronous with the
initial medical treatment should be considered as soon as
possible due to the catastrophic potential for the rupture of a
papillary muscle. Although the overall mortality for CS in the
SHOCK trial (60%) was lower than the ﬁgures given in
previous reports (80%–90%), it still remains extremely and
unacceptably high[18,40,41]. The reduced mortality rate was
explained with increased LV assist with IABP device and
improved revascularization techniques and strategies. In the
SHOCK Trial Registry, hospital mortality rate was around
40% for patients in whom mitral valve surgery was
performed[9,18]. Mitral valve surgery encompasses multiple
strategies including mitral valve repair and mitral valve
replacement. If there is a partial papillary muscle rupture with
limited necrosis and the tissues were found suitable for repair
at the time of surgery, valve repair may be preferred over
replacement. However, ruptured papillary muscle is usually
fragile following an acute myocardial infarction and the
preferable procedure is the valve replacement that provides
long term durability. Fortunately, complete rupture of the
papillary muscle is an extremely rare complication[11]. Addition
of coronary revascularization to mitral valve surgery is
associated with improved short and long term outcomes. The
median time to surgery (combined valve replacement andrevascularization) was seven days in one trial[2,11,38,42]. Although
emergent or urgent surgery with IABP support in early period
after Ml was advocated due to the risk of sudden
hemodynamic collapse, postponing the intervention up to a
couple of weeks was associated with lower surgical mortality
(17% for acute MR) in several studies, if patients did not
fulﬁll criteria for shock or did not have initial hemodynamic
instability. This period is for the development of ﬁbrotic
tissue[11,43–50]. When emergent valve surgery is needed,
additional surgical revascularization did not confer any
mortality beneﬁt in the early period (27.3% vs. 26.4%;
P > 0.05), but was associated with a signiﬁcant improvement
in long term survival up to 15 years after the index event
(additional CABG group: 64% vs. no additional CABG group:
23%; P < 0.001)[2]. Emergency surgery, however, is
fundamental in patients with cardiogenic shock as the survival
is better when the time period between the onset of symptoms
and surgical intervention is shorter[43].
8. Conclusions
High mortality remains as the main problem despite im-
provements in surgical and revascularization strategies. To avoid
catastrophic consequences, diagnosis should be conﬁrmed
rapidly and deﬁnitely, with subsequent referral to surgery as
soon as possible. Emergent medical therapy should be initiated
immediately after conﬁrmation of the diagnosis since patients
may rapidly deteriorate and die while waiting for surgery. Cli-
nicians should be aware of mechanical complications following
AMI, and attention should be given to patients presenting with
non-ST elevation MI, patients having an inferior or posterior
STEMI, and particularly for women with acute coronary events
owing to the fact that majority of the patients with severe MR
with or without shock were female (52% vs. 37%, P = 0.004)
according to the SHOCK Trial results[9].
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